BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23830351)

  • 21. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
    Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
    Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant.
    Schmidt H; Würl P; Taubert H; Meye A; Bache M; Holzhausen HJ; Hinze R
    Genes Chromosomes Cancer; 1999 Jul; 25(3):205-11. PubMed ID: 10379866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours.
    Storlazzi CT; Brekke HR; Mandahl N; Brosjö O; Smeland S; Lothe RA; Mertens F
    J Pathol; 2006 Aug; 209(4):492-500. PubMed ID: 16721726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array.
    Mantripragada KK; Díaz de Ståhl T; Patridge C; Menzel U; Andersson R; Chuzhanova N; Kluwe L; Guha A; Mautner V; Dumanski JP; Upadhyaya M
    Genes Chromosomes Cancer; 2009 Oct; 48(10):897-907. PubMed ID: 19603524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors.
    Tawbi H; Thomas D; Lucas DR; Biermann JS; Schuetze SM; Hart AL; Chugh R; Baker LH
    Oncologist; 2008 Apr; 13(4):459-66. PubMed ID: 18448562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor.
    Du X; Yang J; Ylipää A; Zhu Z
    J Hematol Oncol; 2013 Dec; 6():93. PubMed ID: 24341609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53.
    Høland M; Kolberg M; Danielsen SA; Bjerkehagen B; Eilertsen IA; Hektoen M; Mandahl N; van den Berg E; Smeland S; Mertens F; Sundby Hall K; Picci P; Sveen A; Lothe RA
    Mod Pathol; 2018 Nov; 31(11):1694-1707. PubMed ID: 29946184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
    Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
    Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway.
    Berner JM; Sørlie T; Mertens F; Henriksen J; Saeter G; Mandahl N; Brøgger A; Myklebost O; Lothe RA
    Genes Chromosomes Cancer; 1999 Oct; 26(2):151-60. PubMed ID: 10469453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
    Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
    Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
    Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
    Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant peripheral nerve sheath tumors with high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants.
    Mahller YY; Rangwala F; Ratner N; Cripe TP
    Pediatr Blood Cancer; 2006 Jun; 46(7):745-54. PubMed ID: 16124003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
    Høland M; Berg KCG; Eilertsen IA; Bjerkehagen B; Kolberg M; Boye K; Lingjærde OC; Guren TK; Mandahl N; van den Berg E; Palmerini E; Smeland S; Picci P; Mertens F; Sveen A; Lothe RA
    EBioMedicine; 2023 Nov; 97():104829. PubMed ID: 37837931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
    Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
    Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
    Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
    Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis.
    Lothe RA; Karhu R; Mandahl N; Mertens F; Saeter G; Heim S; Borresen-Dale AL; Kallioniemi OP
    Cancer Res; 1996 Oct; 56(20):4778-81. PubMed ID: 8840998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.
    Mertens F; Dal Cin P; De Wever I; Fletcher CD; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van Den Berghe H; Vanni R; Willén H
    J Pathol; 2000 Jan; 190(1):31-8. PubMed ID: 10640989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
    Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.